IGC Pharma, Inc. Share Price
Stocks
IGC
US45408X3089
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
NYSE
21:00:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.2815 USD | -2.90% |
|
-4.87% | +0.04% |
| Market Cap | 29.1M 25.04M 23.58M 21.49M 40.2M 2.77B 40.36M 279M 108M 1.41B 109M 107M 4.47B | P/E 2026 * |
-2.82x | P/E 2027 * | -3.52x |
|---|---|---|---|---|---|
| Enterprise Value | 29.1M 25.04M 23.58M 21.49M 40.2M 2.77B 40.36M 279M 108M 1.41B 109M 107M 4.47B | EV / Sales 2026 * |
30.4x | EV / Sales 2027 * | 30.4x |
| Free-Float |
86.49% | Yield 2026 * |
-
| Yield 2027 * | - |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| IGC | Delayed | |
CBOE
| IGC | Real-time | |
|
Deutsche Boerse AG
| IGS1 | Delayed | |
|
Börse Stuttgart
| IGS1 | Delayed | |
|
Tradegate
| IGS1 | Real-time | |
|
Boerse Muenchen
| IGS1 | Real-time |
| 1 day | -2.90% | ||
| 1 week | -4.87% | ||
| Current month | -5.92% | ||
| 1 month | +9.70% | ||
| 3 months | -1.23% | ||
| 6 months | -2.86% | ||
| Current year | +0.04% |
| 1 week | 0.28 |  | 0.3 |
| 1 month | 0.27 | | 0.34 |
| Current year | 0.24 | | 0.36 |
| 1 year | 0.24 | | 0.45 |
| 3 years | 0.24 | | 0.91 |
| 5 years | 0.24 | | 1.79 |
| 10 years | 0.19 | | 14.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ram Mukunda
CEO | Chief Executive Officer | 67 | 28/04/2005 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 55 | 08/05/2018 |
Benysh Qureshi
COO | Chief Operating Officer | - | 31/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Ram Mukunda
CHM | Chairman | 67 | 28/04/2005 |
Claudia Grimaldi
BRD | Director/Board Member | 55 | 22/03/2022 |
Richard Prins
CHM | Chairman | 69 | 31/12/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Founder | 2,226,475 | 2.2244% | ||
| 30/06/26 | Free | Chief Financial Officer | 2,048,378 | 2.0465% | ||
| 01/04/26 | Exercice | Chairman | 340,000 | 0.3441% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.90% | -4.87% | -32.98% | -27.76% | 29.97M | |
| -3.24% | -6.89% | -5.65% | +11.20% | 48.01B | |
| +0.17% | -0.74% | +407.28% | +546.58% | 44.44B | |
| -0.86% | -2.60% | +35.51% | +20.35% | 42.67B | |
| -0.14% | -2.98% | -0.04% | +82.21% | 39.96B | |
| 0.00% | -2.61% | +13.09% | +42.33% | 32.75B | |
| -3.44% | -2.43% | - | - | 17.74B | |
| -0.78% | -1.13% | +20.74% | +116.26% | 16.49B | |
| -0.37% | -0.87% | +10.98% | +30.93% | 14.38B | |
| -0.86% | -4.60% | +76.86% | +39.36% | 13.4B | |
| Average | -1.24% | -1.40% | +58.42% | +95.72% | 26.99B | |
| Weighted average by Cap. | -1.04% | -1.76% | +84.47% | +131.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 958K 824K 776K 707K 1.32M 91.16M 1.33M 9.2M 3.56M 46.44M 3.6M 3.52M 147M | 958K 824K 776K 707K 1.32M 91.16M 1.33M 9.2M 3.56M 46.44M 3.6M 3.52M 147M |
| Net income | -10.02M -8.63M -8.12M -7.4M -13.85M -954M -13.9M -96.26M -37.2M -486M -37.64M -36.82M -1.54B | -8.51M -7.32M -6.89M -6.28M -11.75M -810M -11.8M -81.7M -31.58M -412M -31.95M -31.25M -1.31B |
| Net Debt | - | - |
Employees
70
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$0.2815 | -2.90% | 344,994 |
| 08/09/26 | US$0.2899 | -2.72% | 572,295 |
| 04/09/26 | US$0.2980 | -0.17% | 378,027 |
| 03/09/26 | US$0.2985 | +0.88% | 349,306 |
| 02/09/26 | US$0.2959 | -0.27% | 458,195 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2815USD
Average target price
6.000USD
Spread / Average Target
+2,031.44%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IGC Stock
Select your edition
All financial news and data tailored to specific country editions
